AAMER ABBAS

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology EL PASO, TX NPI 1508975772

General Payments — all program years on this page

$54,270.10

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 179
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $295.82 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $295.8215

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $27,866.3348
2019 $18,899.2450
2020 $3,669.6513
2021 $309.8120
2022 $2,899.9121
2023 $329.3412
2024 $295.8215

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078209337 Janssen Pharmaceuticals, Inc $16.19 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086714851 Novartis Pharmaceuticals Corporation $22.62 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086714855 Novartis Pharmaceuticals Corporation $24.44 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086714867 Novartis Pharmaceuticals Corporation $18.24 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086714869 Novartis Pharmaceuticals Corporation $20.88 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086714873 Novartis Pharmaceuticals Corporation $8.77 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086714877 Novartis Pharmaceuticals Corporation $20.08 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086714879 Novartis Pharmaceuticals Corporation $19.63 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101853909 E.R. Squibb & Sons, L.L.C. $14.82 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111507275 Amgen Inc. $42.26 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039624 Boehringer Ingelheim Pharmaceuticals, Inc. $14.86 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039626 Boehringer Ingelheim Pharmaceuticals, Inc. $19.34 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132317989 SCPHARMACEUTICALS INC. $13.37 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146915734 Philips North America LLC $14.92 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154054022 iRhythm Technologies, Inc. $25.40 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.